Shares of Spero Therapeutics Inc. SPRO, +204.20% soared 188.4% in trading on Thursday morning after the company signed an exclusive license agreement with GlaxoSmithKline GSK, -0.12% for its experimental antibiotic Read more
Shares of Spero Therapeutics Inc. SPRO, +204.20% soared 188.4% in trading on Thursday morning after the company signed an exclusive license agreement with GlaxoSmithKline GSK, -0.12% for its experimental antibiotic Read more